The UroLift System is a proven, minimally invasive technology for treating lower urinary tract symptoms due to benign prostatic hyperplasia (BPH). The UroLift permanent implants, delivered during a minimally invasive transurethral outpatient procedure, relieve prostate obstruction and open the urethra directly without cutting, heating, or removing prostate tissue. Clinical data from a pivotal 206-patient randomized controlled study showed that patients with enlarged prostate receiving UroLift implants reported rapid and durable symptomatic and urinary flow rate improvement without compromising sexual function.*1,2 Patients also experienced significant improvement in quality of life. The UroLift System is available in the U.S., Europe, Australia, Canada, Mexico and South Korea.
*No instances of new, sustained erectile or ejaculatory dysfunction
1. McVary, J Sex Med 2014
2. Roehrborn, J Urology 2013 LIFT Study
Company’s Keywords:
1
medical devices
CSC Corporate Domains, Hubspot, Nginx, reCAPTCHA, Google Maps (Non Paid Users), Facebook Custom Audiences, WordPress.org, Google Analytics, Facebook Login (Connect), Wistia, YouTube, Linkedin Marketing Solutions, Facebook Widget, Mobile Friendly, Google Maps